miR-1301-3p acts as oncogene that accelerates the process of prostate carcinogenesis through targeting PPP2R2C (11) and anti-oncogene by inhibiting cell proliferation in glioma (12). The gene discussed is PPP2R2C; the disease is central nervous system cancer.